标题/作者	年份
The pathophysiology of gestational diabetes mellitus JF Plows, JL Stanley, PN Baker, CM Reynolds, MH Vickers International journal of molecular sciences 19 (11), 3342	2018
Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial Y Yamada, H Katagiri, Y Hamamoto, S Deenadayalan, A Navarria, ... The Lancet Diabetes & Endocrinology 8 (5), 377-391	2020
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial D Yabe, J Nakamura, H Kaneto, S Deenadayalan, A Navarria, M Gislum, ... The Lancet Diabetes & Endocrinology 8 (5), 392-406	2020
Esaxerenone (CS-3150) in patients with type 2 diabetes and microalbuminuria (ESAX-DN): phase 3 randomized controlled clinical trial S Ito, N Kashihara, K Shikata, M Nangaku, T Wada, Y Okuda, ... Clinical journal of the American Society of Nephrology: CJASN 15 (12), 1715	2020
Efficacy and safety of esaxerenone (CS-3150) for the treatment of type 2 diabetes with microalbuminuria: a randomized, double-blind, placebo-controlled, phase II trial S Ito, K Shikata, M Nangaku, Y Okuda, T Sawanobori Clinical journal of the American Society of Nephrology: CJASN 14 (8), 1161	2019
Shortage of energy intake rather than protein intake is associated with sarcopenia in elderly patients with type 2 diabetes: A cross‐sectional study of the KAMOGAWA‐DM cohort T Okamura, A Miki, Y Hashimoto, A Kaji, R Sakai, T Osaka, M Hamaguchi, ... Journal of diabetes 11 (6), 477-483	2019
Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial E Wada, T Onoue, T Kobayashi, T Handa, A Hayase, M Ito, M Furukawa, ... BMJ Open Diabetes Research and Care 8 (1), e001115	2020
Efficacy and safety of imeglimin monotherapy versus placebo in Japanese patients with type 2 diabetes (TIMES 1): a double-blind, randomized, placebo-controlled, parallel-group, multicenter phase 3 trial J Dubourg, P Fouqueray, C Thang, JM Grouin, K Ueki Diabetes Care 44 (4), 952-959	2021
Indirect insulin resistance detection: Current clinical trends and laboratory limitations S Placzkowska, L Pawlik-Sobecka, I Kokot, A Piwowar Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 163 (3), 187-199	2019
Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus M Gouda, M Matsukawa, H Iijima Diabetes, metabolic syndrome and obesity: targets and therapy, 647-658	2018
JCS 2018 guideline on diagnosis of chronic coronary heart diseases M Yamagishi, N Tamaki, T Akasaka, T Ikeda, K Ueshima, S Uemura, ... Circulation journal 85 (4), 402-572	2021
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second‐line therapy: results from the global DISCOVER study programme A Nicolucci, B Charbonnel, MB Gomes, K Khunti, M Kosiborod, ... Diabetes, Obesity and Metabolism 21 (11), 2474-2485	2019
Efficacy and safety of ipragliflozin add‐on therapy to insulin in Japanese patients with type 1 diabetes mellitus: a randomized, double‐blind, phase 3 trial K Kaku, H Isaka, T Sakatani, J Toyoshima Diabetes, Obesity and Metabolism 21 (10), 2284-2293	2019
Retrospective nationwide study on the trends in first‐line antidiabetic medication for patients with type 2 diabetes in Japan R Bouchi, T Sugiyama, A Goto, K Imai, N Ihana‐Sugiyama, M Ohsugi, ... Journal of Diabetes Investigation 13 (2), 280-291	2022
Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes: a 24‐week, randomized, double‐blind, placebo‐controlled, dose‐ranging phase 2b trial J Dubourg, K Ueki, JM Grouin, P Fouqueray Diabetes, Obesity and Metabolism 23 (3), 800-810	2021
Hyperuricemia predicts the risk for developing hypertension independent of alcohol drinking status in men and women: the Saku study Y Tatsumi, K Asayama, A Morimoto, M Satoh, N Sonoda, N Miyamatsu, ... Hypertension Research 43 (5), 442-449	2020
Diabetes mellitus and other cardiovascular risk factors in lower-extremity peripheral artery disease versus coronary artery disease: an analysis of 1,121,359 cases from the nationwide databases M Takahara, O Iida, S Kohsaka, Y Soga, M Fujihara, T Shinke, T Amano, ... Cardiovascular diabetology 18, 1-9	2019
Gestational diabetes mellitus screening and diagnosis UY Sert, AS Ozgu-Erdinc Diabetes: from Research to Clinical Practice: Volume 4, 231-255	2021
Effects of nutritional strategies on glucose homeostasis in gestational diabetes mellitus: a systematic review and network meta-analysis S Jin, L Sha, J Dong, J Yi, Y Liu, Z Guo, B Hu Journal of Diabetes Research 2020	2020
Blood pressure and development of cardiovascular disease in Koreans with type 2 diabetes mellitus MK Kim, K Han, ES Koh, ES Kim, MK Lee, GE Nam, HS Kwon Hypertension 73 (2), 319-326	2019

1 - 20

计算机程序会自动估算并确定日期和引用次数。